Assessment of anti SARS-CoV-2 antibodies present in convalescent plasma donors aimed at being used in COVID-19 treatment

Journal Title: One Health & Risk Management - Year 2021, Vol 2, Issue 2

Abstract

Introduction. Currently, COVID-19 treatment includes several options, including the use of convalescent plasma. Therefore, the presence of anti-SARS-CoV-2 in blood donors after the clinical recovery of COVID-19, depending on their place of residence, age and the clinical manifestation of the disease is of scientific-practical interest. Material and methods. A total of 119 donors among patients were examined, namely males aged 18-60 years, having a past history of COVID-19 disease, being confirmed by PCR and treated, showing a negative PCR-based test result, which was performed at least 14 days after clinical recovery. The presence/absence of anti-SARS-CoV-2 was assessed by enzyme-linked immunosorbent assay. Results. The obtained data showed that 87.4% of plasma donors responded to COVID-19 infection by anti-SARS-CoV-2 IgG expression, which is predominantly found in the 26-35 age group. Most donors experienced mild and medium clinical forms. It is important to note that all severe clinical manifestations of the infection were followed by the formation of anti-SARS-CoV-2 IgG. Urban living environment was predominantly found in convalescent donors (75.0%), which indicates that they are better informed by medical institutions. Conclusions. The study shows that male blood donors aged 18-60 years, subsequently cured and being positive for anti-SARS-CoV-2 IgG can serve as a source of fresh plasma used for the treatment of COVID-19 patients.

Authors and Affiliations

Constantin SPÎNU, Svetlana CEBOTARI, Octavian SAJIN, Igor SPÎNU, Ala DONOS, Ana VOLNEANSCHI, Igor GOSTEV, Iurie DOPIRA

Keywords

Related Articles

Particularities of respiratory manifestations of COVID-19 infection in children

Introduction. COVID-19 infection is common in the pediatric population, presenting a variety of respiratory manifestations and complications. Material and methods. The study included 64 children from the COVID-19 sect...

Life science professional responsibility in an age of dual-use research

Biotechnology is progressing at an unprecedented pace promising to bring tremendous benefits by responding to health, socio-economic, and environmental challenges. At the same time, cutting-edge life science advances rai...

Case report: acute liver failure induced by paracetamol toxicity

Introduction. Paracetamol is the most commonly used drug across Western Europe and North America. There is no such trend of using Paracetamol in the Republic of Moldova, thus overdose cases are extremely rare. The mechan...

Identification of Salmonella spp. strains in poultry products and their impact on Public Health

Introduction. Poultry meat and eggs represent a risk of contamination with zoonotic bacterial agents. This requires permanent laboratory monitoring throughout the production chain segment. Material and methods. The rese...

Current epidemiological characteristic of chickenpox in Russia

CURRENT EPIDEMIOLOGICAL CHARACTERISTIC OF CHICKENPOX IN RUSSIA Introduction. The varicella vaccine introduction in the National immunization schedule is planned in Russia by 2020. Since 2013, vaccination against chicken...

Download PDF file
  • EP ID EP693652
  • DOI 10.38045/ohrm.2021.2.08
  • Views 128
  • Downloads 0

How To Cite

Constantin SPÎNU, Svetlana CEBOTARI, Octavian SAJIN, Igor SPÎNU, Ala DONOS, Ana VOLNEANSCHI, Igor GOSTEV, Iurie DOPIRA (2021). Assessment of anti SARS-CoV-2 antibodies present in convalescent plasma donors aimed at being used in COVID-19 treatment. One Health & Risk Management, 2(2), -. https://europub.co.uk/articles/-A-693652